Don't miss the opportunity to read it! www.thelancet.com/journals/lan...

Delighted to share that one of our studies in #IPF has been highlighted by @rachelnuwer.bsky.social in @nature.com among the six highlights from lung health research. www.nature.com/articles/d41...

Delighted to share that one of our studies in #IPF has been highlighted by @rachelnuwer.bsky.social in @nature.com among the six highlights from lung health research. www.nature.com/articles/d41...

I am deeply grateful to my supervisors @ciuffreda_lau and @labcflores.bsky.social for their guidance; to my collaborators, for the teamwork and the funding bodies for supporting this work.

Respiratory syncytial virus #RSV is the leading cause of acute lower respiratory tract infections in children <2 years. It can also severely affect adults. Since the introduction of a prophylactic mAbs treatment in Spain, resistant #RSV lineages have been reported.

Acute respiratory distress syndrome #ARDS is a critical condition characterized by respiratory failure, an acute inflammatory response, and the development of non-cardiogenic pulmonary edema. Sepsis is one of the leading causes of #ARDS and has a high mortality ICUs.

Paper alert! Happy for our contribution to another #GIAB resource paper. #ITER @labcflores.bsky.social www.cell.com/cell-genomic...

Looking for a professional opportunity in Tenerife contributing to the largest cohort study so far being built in the country? Want to join the #cohorteimpact project? cohorte-impact.es

Preprint alert! Many studies have established the grounds to increase the diversity in catalogs of genetic variation to optimally represent population-specific particularities and to support Personalized Medicine strategies across populations worldwide.

Paper alert! Immunocompromised patients could suffer a SARS-CoV-2 infection with viral shedding for long periods of time. Sequencing on serial samples of the patient previously evidenced accelerated viral evolution with accumulation of mutations. www.journalofinfection.com/article/S016...

Today was another great day for @labcflores.bsky.social. We have a new Doctor in town. Kudos @evatosco.bsky.social for such a fantastic defense of your PhD. Hope you enjoyed the day despite the nerves of these past months. Glad to share some of the best moments of the day.

Very grateful for the invitation to talk in the World Critical Lung Day (IX Edition; wdcl.com.co) organized by #Fepimcti to share the state-of-the-art in genomics to better characterize infections and how our team leverage these technologies for better care.

📢 WES and telomere analyses in idiopathic pulmonary fibrosis #IPF patients uncovered pathogenic RTEL1 and NAF1 variants through a robust, clinically useful tiered virtual gene panel workflow. 🧬 Read more in the latest issue of #EJHG ⬇️ www.nature.com/articles/s41...

We are delighted to announce that one @labcflores.bsky.social study led by @aitanaag90.bsky.social has received the Award "II Premios Canarias a la Ciencia de la Salud e Investigación Biomédica" for the best scientific publication of the year. Link to the paper: www.thelancet.com/journals/lan...

Delighted to share that our manuscript entitled “A tiered strategy to identify relevant genetic variants in familial pulmonary fibrosis: a proof of concept for the clinical practice” is now published in the @ejhg-journal.bsky.social November issue

I am grateful to CIBERES and CIBERBBN for organizing such an enriching meeting, and to all funding bodies, institutions, and collaborators who made this work possible. @ciberisciii.bsky.social @labcflores.bsky.social #CIBERES #CIBERBBN

Our findings highlight a set of proteins involved in immune regulation and tissue remodelling, which may shed light on the mechanisms driving long-term lung sequelae.

In this study, we explored whether plasma protein levels measured six months after ICU discharge could serve as biomarkers of interstitial lung disease (ILD) in patients who survived a severe COVID-19.

During the event, I presented our work titled: “Interstitial lung disease protein biomarkers in post-COVID patients.”

Last week, I had the pleasure of attending the Jornadas de Personal Investigador Joven CIBERES–CIBERBBN 2025, an inspiring meeting that brought together young researchers from across Spain to exchange ideas, projects, and challenges in biomedical research.

It's been an intense week for us with several of our study results being presented at different research gatherings

🌎La resistencia a los antimicrobianos es una amenaza a escala global. 🤝En Conexión-AMR tenemos claro que este reto solo puede enfrentarse desde múltiples perspectivas y colaborando entre disciplinas. (1/2)

What a nice conference with such inspiring speakers @kottond.bsky.social @francypolverino.bsky.social @jennydickens41.bsky.social Really enjoyed meeting old and new people in the genomics space! Looking forward to the foreseeable progress in the field #RespGen25

Happy to share our results and an update of the genetic studies in #ILD in this meeting. @labcflores.bsky.social

By now, it would not surprise anyone to understand that there are host genetic variants governing severe infection outcomes.

Want to better understand what interstitial lung diseases are and what do we aim for with the project PRECISION-ILD funded by @isciiisalud.bsky.social involving the participation of many researchers from Spain and abroad? Check the project's webpage: precisionepid.com

Want to better understand what interstitial lung diseases are and what do we aim for with the project PRECISION-ILD funded by @isciiisalud.bsky.social involving the participation of many researchers from Spain and abroad? Check the project's webpage: precisionepid.com